Pattern of Cardiovascular Comorbidity in COPD in a Country with Low-smoking Prevalence: Results from Two-population-based Cohorts from Sweden

References

• Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–65.
   PubMed Web of Science ®Google Scholar
• Celli BR, MacNee W, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23(6):932–46.
   PubMed Web of Science ®Google Scholar
• Lundbäck B, Bakke P, Ingebrigtsen T, Lange P, Lindberg A, Soriano JB, Vestbo J. Chronic obstructive pulmonary disease. In: Annesi-Maesano I, Lundbäck B, Viegi G, editors. Respiratory epidemiology Sheffield (UK): ERS Monographs, European Respiratory Society; 2014. p. 1–17.
   Google Scholar
• Stridsman C, Müllerova H, Skär L, Lindberg A. Fatigue in COPD and the impact of respiratory symptoms and heart disease-a population-based study. COPD. 2013;10(2):125–32.
   PubMedGoogle Scholar
• Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33:1165–1185.
   PubMed Web of Science ®Google Scholar
• Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet. 2007;370:797–799.
   PubMed Web of Science ®Google Scholar
• Chatila WM, Thomashov BM, Minai OA, Criner GJ, Make BJ. Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008;5:549–55.
   PubMedGoogle Scholar
• Fabbri LM, Luppi F, Beghe B, Rabe KF. Complex chronic comorbidities of COPD. Eur Respir J. 2008;31:204–212.
   PubMed Web of Science ®Google Scholar
• Meteran H, Backer V, Kyvik KO, Skytthe A, Thomsen SF. Comorbidity between chronic obstructive pulmonary disease and type 2 diabetes: A nation-wide cohort twin study. Respir Med. 2015;109(8):1026–30.
   PubMed Web of Science ®Google Scholar
• Agustí A, Edwards LD, Rennard SI, MacNee W, Tal-Singer L, Miller BE, Vestbo J, Lomas DA, Calverley PMA, Wouters E, et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: A novel phenotype. PLoS One. 2012;7(5):e37483.
   PubMed Web of Science ®Google Scholar
• Hemminki K, Liu X, Ji J, Sundquist K, Sundquist J. Subsequent COPD and lung cancer in patients with autoimmune disease. Eur Respir J. 2011;37(2):463–65.
   PubMed Web of Science ®Google Scholar
• Allipor SD, Mortaz E, Garssen J, Movassaghi M, Mirsaeidi M, Adcock IM. Exosomes and exosomal miRNA in respiratory diseases. Mediators Inflamm. 2016;2016:5628404. Epub 2016 Sep 25.
   PubMedGoogle Scholar
• Gupta SK, Bang C, Thum T. Circulating microRNAs as biomarkers and potential paracrine mediators of cardiovascular disease. Circ Cardiovasc Genet. 2010;3(5):484–88.
   PubMed Web of Science ®Google Scholar
• Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension, and cardiovascular disease in chronic obstructive pulmonary disease. Eur Respir J. 2008;32:962–69.
   PubMed Web of Science ®Google Scholar
• Eriksson B, Lindberg A, Müllerova H, Rönmark E, Lundbäck B. Association of heart diseases with COPD and restrictive lung function-results from a population survey. Respir Med. 2013;107(1):98–106.
   PubMed Web of Science ®Google Scholar
• Lundbäck B, Nyström L, Rosenhall L, Stjernberg N. Obstructive lung disease in northern Sweden: respiratory symptoms assessed in a postal survey. Eur Respir J. 1991;4:257–66.
   PubMed Web of Science ®Google Scholar
• Backman H, Hedman L, Jansson SA, Lindberg A, Lundbäck B, Rönmark E. Prevalence trends in respiratory symptoms and asthma in relation to smoking - two cross-sectional studies ten years apart among adults in northern Sweden. World Allergy Organ J. 2014;7(1):1 [Epub].
   PubMedGoogle Scholar
• Backman H, Eriksson B, Rönmark E, Hedman L, Stridsman C, Jansson SA, Lindberg A, Lundbäck B. Decreased prevalence of moderate to severe COPD over 15 years in northern Sweden. Respir Med. 2016;114:103–10.
   PubMed Web of Science ®Google Scholar
• Lindström M, Kotaniemi J, Jönsson E, Lundbäck B. Smoking, respiratory symptoms and diseases - A comparative study between northern Sweden and northern Finland - Report from the FinEsS study. Chest. 2001;119:852–61.
   PubMed Web of Science ®Google Scholar
• Lötvall J, Ekerljung L, Rönmark EP, Wennergren G, Lindén A, Rönmark E, Torén K, Lundbäck B. West Sweden Asthma Study: Prevalence trends over the last 18 years argues no recent increase in asthma. Respir Res. 2009;10:94 (e-pub).
   PubMed Web of Science ®Google Scholar
• Rönmark EP, Ekerljung L, Lötvall J, Torén K, Rönmark E, Lundbäck B. Large scale questionnaire survey on respiratory health in Sweden: Effects of late- and non-response. Respir Med. 2009;103:1807–15.
   PubMed Web of Science ®Google Scholar
• Ekerljung L, Bjerg A, Bossios A, Axelsson M, Torén K, Wennergren G, Lötvall J, Lundbäck B. Five-fold increase in use of inhaled corticosteroids over 18 years in the general adult population in west Sweden. Respir Med. 2014;108:685–93.
   PubMed Web of Science ®Google Scholar
• Pallasaho P, Lundbäck B, Läspä SL, Jönsson E, Kotanimeni J, Sovijärvi A, Laitinen LA. Increasing prevalence of asthma but not of chronic bronchitis in Finland? Report from the FinEsS-Helsinki Study. Respir Med. 1999;93:798–809.
   PubMed Web of Science ®Google Scholar
• Rönmark EP. The association between eczema, asthma and rhinitis – population studies of prevalence and risk factors among adults [PhD thesis]. [Gothenburg (Sweden)]: University of Gothenburg; 2016, ISBN 978-91-628-9747-5. http://hdl.handle.net/2077/41838.
   Google Scholar
• Kotaniemi J, Lundbäck B, Nieminen M, Sovijärvi A, Laitinen L. Increase of asthma in adults in Northern Finland?–a report from the FinEsS study. Allergy. 2001;56:169–174.
   PubMed Web of Science ®Google Scholar
• Lam HT, Rönmark E, Tuờng, NV, Ekerljung L, Chúc NT, Lundbäck B. Increase in asthma and a high prevalence of bronchitis: results from a population study among adults in urban and rural Vietnam. Respir Med. 2011;105:177–185.
   PubMed Web of Science ®Google Scholar
• Ekerljung L, Rönmark E, Lötvall J, Wennergren G, Torén K, Lundbäck B. Questionnaire layout and wording influence prevalence and risk estimates of respiratory symptoms in a population cohort. Clin Respir J. 2013;7:53–63.
   PubMed Web of Science ®Google Scholar
• Backman H, Lindberg A, Odén A, Ekerljung L, Hedman L, Kainu A, Sovijärvi A, Lundbäck B, Rönmark E. Reference values for spirometry – Report from the Obstructive Lung Disease in Northern Sweden (OLIN) Studies. Eur Clin Respir J. 2015; 2:26375 (E-pub).
   PubMed Web of Science ®Google Scholar
• Backman H, Lindberg A, Sovijärvi A, Larsson K, Lundbäck B, Rönmark E. Evaluation of the global lung function initiative 2012 reference values for spirometry in a Swedish population sample. BMC Pulm Med. 2015;15:26 (E-pub).
   PubMed Web of Science ®Google Scholar
• Bakke PS, Rönmark E, Eagan T, Pistelli F, Annesi-Maesano I, Maly M, Meren M, Vermeire P, Vestbo J, Viegi G, et al. Recommendations for epidemiological studies on COPD. Eur Respir J. 2011;38(6):1261–1277.
   PubMed Web of Science ®Google Scholar
• Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, Enright PL, Hankinson JL, Ip MSM, Zheng J, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324–1343.
   PubMed Web of Science ®Google Scholar
• Celli BR, Decramer M, Wedzicha JA, Wilson KC, Agustí AA, Criner GJ, MacNee W, Make BJ, Rennard SI, Stockley RA, et al. An official American Thoracic Society/European Respiratory Society statement: Research questions in COPD. Eur Respir Rev. 2015;24:159–172.
   PubMed Web of Science ®Google Scholar
• Hnizdo E, Glindmeyer HW, Petsonk EL, Enright P, Buist AS. Case definitions for chronic obstructive pulmonary disease. COPD. 2006 Jun;3(2):95–100.
   PubMedGoogle Scholar
• WHO on BMI WHO. Global Database on Body Mass Index, World Health Organization. Available from: http://apps.who.int/bmi/index.jsp?introPage=intro_3.html. Last update: 11/10/2016. Retrieved 11th of October 2016.
   Google Scholar
• van Manen JG, Bindels PJE, Jtzermans CJI, van der Zee JS, Bottema BJAM, Schade E. Prevalence of comorbidity in patients with a chronic airway obstruction and controls over the age of 40. J Clin Epidemiol. 2001;54:287–293.
   PubMed Web of Science ®Google Scholar
• Cunningham TJ. Ford ES. Rolle IV. Wheaton AG. Croft JB. Associations of self-reported cigarette smoking with chronic obstructive pulmonary disease and co-morbid chronic conditions in the United States. COPD. 2015;12:276–286.
   PubMedGoogle Scholar
• Nilsson PM, Nilsson JA, Berglund G. Population-attributable risk of coronary heart disease risk factors during long-term follow-up: the Malmö Preventive Project. J Intern Med. 2006;260:134–141.
   PubMed Web of Science ®Google Scholar
• Cazzola M, Bettoncelli G, Sessa E, Cricelli C, Biscione G. Prevalence of comorbidities in patients with chronic obstructive pulmonary disease. Respiration. 2010;80:112–119.
   PubMed Web of Science ®Google Scholar
• Lindberg A, Larsson L-G, Rönmark E, Lundbäck B. Co-morbidity in mild-to-moderate COPD: comparison to normal and restrictive lung function. COPD. 2011;8:421–428.
   PubMedGoogle Scholar
• Nilsson U, Johansson B, Eriksson B, Blomberg A, Lundbäck B, Lindberg A. Ischemic heart disease among subjects with and without chronic obstructive pulmonary disease - ECG-findings in a population-based cohort study. BMC Pulm Med. 2015;15:156.
   PubMed Web of Science ®Google Scholar
• Wacker ME, Jörres RA, Karch A, Wilke S, Heinrich J, Karrasch S, Schulz H, Peters A, Gläser S, Ewert R, et al. COSYCONET study group. Relative impact of COPD and comorbidities on generic health-related quality of life: a pooled analysis of the COSYCONET patient cohort and control subjects from the KORA and SHIP studies. Respir Res. 2016;17(1):81 (E-pub).
   PubMedGoogle Scholar
• Hawkins NM, Petrie MC, Jhund PS, Chalmers GW, Dunn FG, McMurray JJ. Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur J Heart Fail. 2009;11(2):130–39.
   PubMed Web of Science ®Google Scholar
• Fabricius P, Løkke A, Marott JL, Vestbo J., Lange P. Prevalence of COPD in Copenhagen. Respir Med. 2011;105(3):410–417.
   PubMed Web of Science ®Google Scholar
• Sode BF, Dahl M, Nordestgaard BG. Myocardial infarction and other co-morbidities in patients with chronic obstructive pulmonary disease: a Danish nationwide study of 7.4 million individuals. Eur Heart J. 2011;19:2365–2375.
   Google Scholar
• Ingolfsson I Ö, Sigurdsson G, Sigvaldason H, Thorgeirsson G, Sigfusson N. A marked decline in the prevalence and incidence of intermittent claudication in icelandic men 1968–1986: A strong relationship to smoking and serum cholesterol—The Reykjavik study. J Clin Epidemiol. 1994;47(11):1237–1243.
   PubMed Web of Science ®Google Scholar
• Björnsson E, Plaschke P, Norrman E, Janson C, Lundbäck B, Rosenhall A, Lindholm N, Rosenhall L, Berglund E, Boman G. Symptoms related to asthma and chronic bronchitis in three areas of Sweden. Eur Respir J. 1994;7(12):2146–2153.
   PubMed Web of Science ®Google Scholar
• Torén K, Hermansson BA. Incidence rate of adult-onset asthma in relation to age, sex, atopy and smoking: a Swedish population-based study of 15813 adults. Int J Tuberc Lung Dis. 1999;3(3):192–97.
   PubMed Web of Science ®Google Scholar
• Lindberg A, Jonsson A-C, Rönmark E, Lundgren R, Larsson L-G, Lundbäck B. Prevalence of COPD according to BTS, ERS, GOLD and ATS criteria in relation to doctor´s diagnosis, symptoms, age, gender, and smoking habits. Respiration. 2005;72(5):471–479.
   PubMed Web of Science ®Google Scholar
• Çolak Y, Afzal S, Nordestgaard BG, Lange P. Majority of never-smokers with airflow limitation do not have asthma: the Copenhagen General Population Study. Thorax. 2016;71:614–623.
   PubMed Web of Science ®Google Scholar
• Thomsen M, Nordestgaard BG, Vestbo J, Lange P. Characteristics and outcomes of chronic obstructive pulmonary disease in never smokers in Denmark: a prospective population study. Lancet Respir Med. 2013;1(7):543–550.
   PubMed Web of Science ®Google Scholar
• Hagstad S, Backman H, Bjerg A, Ekerljung L, Xiong Y, Hedman L, Lindberg A, Torén K, Lötvall J, Rönmark E, et al. Prevalence and risk factors of COPD among never-smokers in two areas of Sweden – occupational exposure to gas, dust or fumes is an important risk factor. Respir Med. 2015;109(11):1439–1445.
   PubMed Web of Science ®Google Scholar
• Rönmark E, Lundqvist A, Lundbäck B, Nyström L. Non-responders to a postal questionnaire on respiratory symptoms and diseases. Eur J Epidemiol. 1999;15: 293–299.
   PubMed Web of Science ®Google Scholar
• Statistics Sweden Living Conditions Surveys (ULF/SILC). Available from: http://www.scb.se/en_/Finding-statistics/Statistics-by-subject-area/Living-conditions/Living-conditions/Living-Conditions-Surveys-ULFSILC/. Last accessed 11th of October 2016.
   Google Scholar
• Okura Y, Urban L, Mahoney W, Jacobsen S, Rodeheffer R. Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol. 2004;57:1096–1103.
   PubMed Web of Science ®Google Scholar